These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39125633)

  • 1. Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein-Barr Virus.
    Košćak Lukač J; Baronica KB; Šućur A; Sremec J; Tomasović S; Baronica R; Kelava T; Grčević D; Kovačić N
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
    J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
    Cocuzza CE; Piazza F; Musumeci R; Oggioni D; Andreoni S; Gardinetti M; Fusco L; Frigo M; Banfi P; Rottoli MR; Confalonieri P; Rezzonico M; Ferrò MT; Cavaletti G;
    PLoS One; 2014; 9(4):e94497. PubMed ID: 24722060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the effect of vitamin D
    Rolf L; Muris AH; Mathias A; Du Pasquier R; Koneczny I; Disanto G; Kuhle J; Ramagopalan S; Damoiseaux J; Smolders J; Hupperts R
    Mult Scler; 2018 Sep; 24(10):1280-1287. PubMed ID: 28731372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
    Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-dose vitamin D
    Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
    Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis.
    Hon GM; Hassan MS; van Rensburg SJ; Erasmus RT; Matsha TE
    Metab Brain Dis; 2012 Sep; 27(3):311-8. PubMed ID: 22407028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
    Karampoor S; Zahednasab H; Etemadifar M; Keyvani H
    J Neuroimmunol; 2018 Jul; 320():11-14. PubMed ID: 29759135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
    Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
    Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients.
    Mohammadinasr M; Montazersaheb S; Hosseini V; Kahroba H; Talebi M; Molavi O; Ayromlou H; Hejazi MS
    Cytokine; 2024 Jul; 179():156624. PubMed ID: 38692184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
    Dooley MM; de Gannes SL; Fu KA; Lindsey JW
    J Neuroimmunol; 2016 Oct; 299():147-151. PubMed ID: 27725113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.